Serum Fibroblast Growth Factor 21 as a Novel Biomarker in Prediction of Coronary Artery Disease Severity
Mervat M. Khalaf, Salwa Fayez & Taha Azouz · Journal of Advances in Medicine and Medical Research · 2016
Aims: To evaluate serum FGF-21 concentrations in coronary heart disease patients (CHD) whether or not associated with diabetes and/or hypertension. It also investigated the possible association between serum FGF21 and the coronary angiographic findings in terms of number of coron...
Open access
Research Article
10.9734/BJMMR/2016/29581